|
Volumn 62, Issue 6, 2002, Pages 1737-1742
|
Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
CD4 ANTIGEN;
CD8 ANTIGEN;
CYTOKINE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GAMMA INTERFERON;
HEAT SHOCK PROTEIN 110;
IMMUNOGLOBULIN G ANTIBODY;
IMMUNOGLOBULIN G1;
IMMUNOGLOBULIN G2A;
RECOMBINANT VACCINE;
ANIMAL MODEL;
ANTIGEN SPECIFICITY;
ARTICLE;
CANCER IMMUNOLOGY;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
IMMUNIZATION;
MOUSE;
NONHUMAN;
ONCOGENE NEU;
PRIORITY JOURNAL;
PROTEIN BINDING;
T LYMPHOCYTE;
TRANSGENIC MOUSE;
VACCINATION;
ANIMALS;
CANCER VACCINES;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
EPITOPES;
FEMALE;
HSP110 HEAT-SHOCK PROTEINS;
HSP70 HEAT-SHOCK PROTEINS;
IMMUNOGLOBULIN G;
INTERFERON TYPE II;
MICE;
MICE, INBRED C57BL;
MICE, SCID;
RECEPTOR, ERBB-2;
VACCINES, SYNTHETIC;
|
EID: 0037086266
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (88)
|
References (35)
|